menu ☰
menu ˟

Liraglutide for the treatment of type 2 diabetes mellitus

Creator:

National Institute for Health and Clinical Excellence (NICE)

Subject Keywords: DIABETES MELLITUS, MEDICAL TREATMENT
Set: Chronic Conditions
Conditions
Diabetes
Type: Guideline
Region: United Kingdom
Description:

NICE recommends liraglutide taken at a dose of 1.2 mg once a day as a possible treatment for some people with type 2 diabetes mellitus. However, NICE does not recommend liraglutide taken at a higher dose of 1.8 mg once a day. NICE looks at how well treatments work, and also at how well they work in relation to how much they cost the NHS. NICE recommended liraglutide given with one other drug for diabetes in these circumstances because there is a clinical need for people whose only alternative is early treatment with insulin. NICE recommended liraglutide given with two other drugs for diabetes in these circumstances because its cost is justified by the benefits it provides. There was no evidence to show that liraglutide works better if the dose is increased from 1.2 mg to 1.8 mg, so NICE did not recommend the higher dose.

Date:

27/10/2010

Rights: © National Institute for Health and Clinical Excellence
Suggested citation:

National Institute for Health and Clinical Excellence (NICE). (2010) Liraglutide for the treatment of type 2 diabetes mellitus [Online]. Available from: http://www.thehealthwell.info/node/42592 [Accessed: 22nd September 2017].

  

View your saved citations and reading lists

Contributor:

Other partner websites
 
Click here to view all the resources gathered from this organisation's website.